Health insurance allowance to be possible for antibiotic Tygacil

Wyeth Korea says patients will be allowed to receive insurance reimbursement over its antibiotic Tygacil as a result of the recent pricing negotiation with the National Health Insurance Corporation.

Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil.

Tigecycline provides an expanded broad spectrum of in vitro activity and is indicated f...